Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT02319135 · COMPLETED
Trial details
- NCT number
- NCT02319135
- Sponsor
- PETHEMA Foundation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2018-10-28
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.